FNY Partners Fund’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q3
Sell
-15
Closed -$16K 515
2017
Q2
$16K Buy
+15
New +$16K ﹤0.01% 333